Search results

Order by most recent / most popular / relevance

Results: 1-10 of 98

US and European approaches to antibody patents

FB Rice
-
European Union, USA
-
June 13 2013

When monoclonal antibodies were first produced in 1974, Kohler and Milstein predicted that they “could be valuable for medical and industrial use”

Pharmaceutical trade marks case law round up for 2012early 2013

Corrs Chambers Westgarth
-
Australia, European Union, USA
-
June 6 2013

A brief wrap-up of recent decisions relating to trade marks in the pharma space from the EU, the United States and Australia

Re-sale of digital music: US v EU approach

William Fry
-
European Union, USA
-
June 4 2013

US - Rights Not Exhausted After First Sale ReDigi, a US company, allows its customers to re-sell their digital music through its online marketplace

Overview of patent-statutory subject matter in biotechnology

CCPIT Patent & Trademark Law Office
-
China, European Union, Japan, USA
-
April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Intellectual Property & Technology, Media and Telecommunications newsletter (number 32)

Herbert Smith Freehills LLP
-
European Union, USA
-
May 27 2013

In Microsoft Corporation v Motorola Inc. the Washington District Court recently issued its findings (25 April 2013) setting out a list of "Economic

2013 antitrust merger enforcement update and outlook

Gibson Dunn & Crutcher LLP
-
European Union, USA
-
March 21 2013

Our 2012 Antitrust Merger Enforcement Update and Outlook reported on a number of emerging trends and initiatives by antitrust enforcers around the

General counsel update

Herbert Smith Freehills LLP
-
China, European Union, Germany, Hong Kong, Indonesia, Mongolia, Singapore, United Kingdom, USA
-
July 11 2012

This is the thirtieth in our series of general counsel updates which aim to summarise major developments in key areas

Patent claims for ‘personalised medicines’

Mewburn Ellis LLP
-
European Union, USA
-
February 7 2013

As previously reported the US Supreme Court, in Mayo v. Prometheus, recently invalidated Prometheus's diagnostic claims - directed to a method of

April 2013 Intellectual Property Quarterly Newsletter

Hogan Lovells
-
China, European Union, France, Germany, Italy, Netherlands, Spain, United Kingdom, USA
-
April 25 2013

In this edition, we continue our coverage of significant IP developments in Europe, Asia, and the United States

next >

Search results

US and European approaches to antibody patents

Pharmaceutical trade marks case law round up for 2012early 2013

Re-sale of digital music: US v EU approach

Overview of patent-statutory subject matter in biotechnology

Dispelling the Myriad gene patent harmonization myth

Intellectual Property & Technology, Media and Telecommunications newsletter (number 32)

2013 antitrust merger enforcement update and outlook

General counsel update

Patent claims for ‘personalised medicines’

April 2013 Intellectual Property Quarterly Newsletter

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea